Skip to main content
. 2017 Sep 9;108(10):2045–2051. doi: 10.1111/cas.13335

Table 2.

Tumor response

No. (n = 71) %
Complete response 0 0
Partial response 38 53.5
Stable disease 21 29.6
Progressive disease 6 8.5
Non‐evaluable 6 8.5
Response rate 38 53.5
95% CI 41.3–65.5
Disease control rate 59 83.1
95% CI 72.3–91.0

Assessed by independent review committee according to Response Evaluation Criteria In Solid Tumors (RECIST) version 1.0. CI, confidence interval.